Report Detail

Pharma & Healthcare Global Orally Dissolving Film Drug Market Research Report 2022

  • RnM4438745
  • |
  • 11 May, 2022
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Summary:

Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
Industry Insights
Due to the COVID-19 pandemic, the global Orally Dissolving Film Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Orally Dissolving Film Drug market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Orally Dissolving Film Drug landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Orodispersible Film accounting for % of the Orally Dissolving Film Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Orally Dissolving Film Drug include GSK, LTS, J&J, Indivior, Pfizer, Sanofi, Church & Dwight, tesa Labtec and Tapemark, etc. In terms of revenue, the global 3 largest players have a % market share of Orally Dissolving Film Drug in 2021.
This report focuses on Orally Dissolving Film Drug volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Orally Dissolving Film Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the Orally Dissolving Film Drug market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
Orodispersible Film
Oromucosal Film
Segment by Application
Hospitals
Drugstores
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
Frequently Asked Questions
Which product segment grabbed the largest share in the Orally Dissolving Film Drug market?
How is the competitive scenario of the Orally Dissolving Film Drug market?
Which are the key factors aiding the Orally Dissolving Film Drug market growth?
Which are the prominent players in the Orally Dissolving Film Drug market?
Which region holds the maximum share in the Orally Dissolving Film Drug market?
What will be the CAGR of the Orally Dissolving Film Drug market during the forecast period?
Which application segment emerged as the leading segment in the Orally Dissolving Film Drug market?
What key trends are likely to emerge in the Orally Dissolving Film Drug market in the coming years?
What will be the Orally Dissolving Film Drug market size by 2028?
Which company held the largest share in the Orally Dissolving Film Drug market?


Table of Contents

    1 Orally Dissolving Film Drug Market Overview

    • 1.1 Product Overview and Scope of Orally Dissolving Film Drug
    • 1.2 Orally Dissolving Film Drug Segment by Type
      • 1.2.1 Global Orally Dissolving Film Drug Sales Growth Rate Comparison by Type (2022-2028)
      • 1.2.2 Orodispersible Film
      • 1.2.3 Oromucosal Film
    • 1.3 Orally Dissolving Film Drug Segment by Application
      • 1.3.1 Global Orally Dissolving Film Drug Sales Comparison by Application: (2022-2028)
      • 1.3.2 Hospitals
      • 1.3.3 Drugstores
      • 1.3.4 Others
    • 1.4 Global Orally Dissolving Film Drug Market Size Estimates and Forecasts
      • 1.4.1 Global Orally Dissolving Film Drug Revenue 2017-2028
      • 1.4.2 Global Orally Dissolving Film Drug Sales 2017-2028
      • 1.4.3 Orally Dissolving Film Drug Market Size by Region: 2017 Versus 2021 Versus 2028

    2 Orally Dissolving Film Drug Market Competition by Manufacturers

    • 2.1 Global Orally Dissolving Film Drug Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Orally Dissolving Film Drug Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Orally Dissolving Film Drug Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Orally Dissolving Film Drug Manufacturing Sites, Area Served, Product Type
    • 2.5 Orally Dissolving Film Drug Market Competitive Situation and Trends
      • 2.5.1 Orally Dissolving Film Drug Market Concentration Rate
      • 2.5.2 The Global Top 5 and Top 10 Largest Orally Dissolving Film Drug Players Market Share by Revenue
      • 2.5.3 Global Orally Dissolving Film Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    3 Orally Dissolving Film Drug Retrospective Market Scenario by Region

    • 3.1 Global Orally Dissolving Film Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Orally Dissolving Film Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Orally Dissolving Film Drug Market Facts & Figures by Country
      • 3.3.1 North America Orally Dissolving Film Drug Sales by Country
      • 3.3.2 North America Orally Dissolving Film Drug Revenue by Country
      • 3.3.3 United States
      • 3.3.4 Canada
    • 3.4 Europe Orally Dissolving Film Drug Market Facts & Figures by Country
      • 3.4.1 Europe Orally Dissolving Film Drug Sales by Country
      • 3.4.2 Europe Orally Dissolving Film Drug Revenue by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Orally Dissolving Film Drug Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Orally Dissolving Film Drug Sales by Region
      • 3.5.2 Asia Pacific Orally Dissolving Film Drug Revenue by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 China Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
    • 3.6 Latin America Orally Dissolving Film Drug Market Facts & Figures by Country
      • 3.6.1 Latin America Orally Dissolving Film Drug Sales by Country
      • 3.6.2 Latin America Orally Dissolving Film Drug Revenue by Country
      • 3.6.3 Mexico
      • 3.6.4 Brazil
      • 3.6.5 Argentina
      • 3.6.6 Colombia
    • 3.7 Middle East and Africa Orally Dissolving Film Drug Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Orally Dissolving Film Drug Sales by Country
      • 3.7.2 Middle East and Africa Orally Dissolving Film Drug Revenue by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 UAE

    4 Global Orally Dissolving Film Drug Historic Market Analysis by Type

    • 4.1 Global Orally Dissolving Film Drug Sales Market Share by Type (2017-2022)
    • 4.2 Global Orally Dissolving Film Drug Revenue Market Share by Type (2017-2022)
    • 4.3 Global Orally Dissolving Film Drug Price by Type (2017-2022)

    5 Global Orally Dissolving Film Drug Historic Market Analysis by Application

    • 5.1 Global Orally Dissolving Film Drug Sales Market Share by Application (2017-2022)
    • 5.2 Global Orally Dissolving Film Drug Revenue Market Share by Application (2017-2022)
    • 5.3 Global Orally Dissolving Film Drug Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 GSK
      • 6.1.1 GSK Corporation Information
      • 6.1.2 GSK Description and Business Overview
      • 6.1.3 GSK Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.1.4 GSK Orally Dissolving Film Drug Product Portfolio
      • 6.1.5 GSK Recent Developments/Updates
    • 6.2 LTS
      • 6.2.1 LTS Corporation Information
      • 6.2.2 LTS Description and Business Overview
      • 6.2.3 LTS Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.2.4 LTS Orally Dissolving Film Drug Product Portfolio
      • 6.2.5 LTS Recent Developments/Updates
    • 6.3 J&J
      • 6.3.1 J&J Corporation Information
      • 6.3.2 J&J Description and Business Overview
      • 6.3.3 J&J Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.3.4 J&J Orally Dissolving Film Drug Product Portfolio
      • 6.3.5 J&J Recent Developments/Updates
    • 6.4 Indivior
      • 6.4.1 Indivior Corporation Information
      • 6.4.2 Indivior Description and Business Overview
      • 6.4.3 Indivior Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Indivior Orally Dissolving Film Drug Product Portfolio
      • 6.4.5 Indivior Recent Developments/Updates
    • 6.5 Pfizer
      • 6.5.1 Pfizer Corporation Information
      • 6.5.2 Pfizer Description and Business Overview
      • 6.5.3 Pfizer Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.5.4 Pfizer Orally Dissolving Film Drug Product Portfolio
      • 6.5.5 Pfizer Recent Developments/Updates
    • 6.6 Sanofi
      • 6.6.1 Sanofi Corporation Information
      • 6.6.2 Sanofi Description and Business Overview
      • 6.6.3 Sanofi Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.6.4 Sanofi Orally Dissolving Film Drug Product Portfolio
      • 6.6.5 Sanofi Recent Developments/Updates
    • 6.7 Church & Dwight
      • 6.6.1 Church & Dwight Corporation Information
      • 6.6.2 Church & Dwight Description and Business Overview
      • 6.6.3 Church & Dwight Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Church & Dwight Orally Dissolving Film Drug Product Portfolio
      • 6.7.5 Church & Dwight Recent Developments/Updates
    • 6.8 tesa Labtec
      • 6.8.1 tesa Labtec Corporation Information
      • 6.8.2 tesa Labtec Description and Business Overview
      • 6.8.3 tesa Labtec Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.8.4 tesa Labtec Orally Dissolving Film Drug Product Portfolio
      • 6.8.5 tesa Labtec Recent Developments/Updates
    • 6.9 Tapemark
      • 6.9.1 Tapemark Corporation Information
      • 6.9.2 Tapemark Description and Business Overview
      • 6.9.3 Tapemark Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.9.4 Tapemark Orally Dissolving Film Drug Product Portfolio
      • 6.9.5 Tapemark Recent Developments/Updates
    • 6.10 Prestige
      • 6.10.1 Prestige Corporation Information
      • 6.10.2 Prestige Description and Business Overview
      • 6.10.3 Prestige Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.10.4 Prestige Orally Dissolving Film Drug Product Portfolio
      • 6.10.5 Prestige Recent Developments/Updates
    • 6.11 Sun Pharma
      • 6.11.1 Sun Pharma Corporation Information
      • 6.11.2 Sun Pharma Orally Dissolving Film Drug Description and Business Overview
      • 6.11.3 Sun Pharma Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.11.4 Sun Pharma Orally Dissolving Film Drug Product Portfolio
      • 6.11.5 Sun Pharma Recent Developments/Updates
    • 6.12 MonoSol
      • 6.12.1 MonoSol Corporation Information
      • 6.12.2 MonoSol Orally Dissolving Film Drug Description and Business Overview
      • 6.12.3 MonoSol Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.12.4 MonoSol Orally Dissolving Film Drug Product Portfolio
      • 6.12.5 MonoSol Recent Developments/Updates
    • 6.13 BioDelivery
      • 6.13.1 BioDelivery Corporation Information
      • 6.13.2 BioDelivery Orally Dissolving Film Drug Description and Business Overview
      • 6.13.3 BioDelivery Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.13.4 BioDelivery Orally Dissolving Film Drug Product Portfolio
      • 6.13.5 BioDelivery Recent Developments/Updates
    • 6.14 Arx
      • 6.14.1 Arx Corporation Information
      • 6.14.2 Arx Orally Dissolving Film Drug Description and Business Overview
      • 6.14.3 Arx Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.14.4 Arx Orally Dissolving Film Drug Product Portfolio
      • 6.14.5 Arx Recent Developments/Updates
    • 6.15 ZIM
      • 6.15.1 ZIM Corporation Information
      • 6.15.2 ZIM Orally Dissolving Film Drug Description and Business Overview
      • 6.15.3 ZIM Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.15.4 ZIM Orally Dissolving Film Drug Product Portfolio
      • 6.15.5 ZIM Recent Developments/Updates
    • 6.16 NAL Pharma
      • 6.16.1 NAL Pharma Corporation Information
      • 6.16.2 NAL Pharma Orally Dissolving Film Drug Description and Business Overview
      • 6.16.3 NAL Pharma Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.16.4 NAL Pharma Orally Dissolving Film Drug Product Portfolio
      • 6.16.5 NAL Pharma Recent Developments/Updates
    • 6.17 AdhexPharma
      • 6.17.1 AdhexPharma Corporation Information
      • 6.17.2 AdhexPharma Orally Dissolving Film Drug Description and Business Overview
      • 6.17.3 AdhexPharma Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.17.4 AdhexPharma Orally Dissolving Film Drug Product Portfolio
      • 6.17.5 AdhexPharma Recent Developments/Updates
    • 6.18 Aavishkar
      • 6.18.1 Aavishkar Corporation Information
      • 6.18.2 Aavishkar Orally Dissolving Film Drug Description and Business Overview
      • 6.18.3 Aavishkar Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.18.4 Aavishkar Orally Dissolving Film Drug Product Portfolio
      • 6.18.5 Aavishkar Recent Developments/Updates
    • 6.19 IntelGenx Corp
      • 6.19.1 IntelGenx Corp Corporation Information
      • 6.19.2 IntelGenx Corp Orally Dissolving Film Drug Description and Business Overview
      • 6.19.3 IntelGenx Corp Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.19.4 IntelGenx Corp Orally Dissolving Film Drug Product Portfolio
      • 6.19.5 IntelGenx Corp Recent Developments/Updates
    • 6.20 APR
      • 6.20.1 APR Corporation Information
      • 6.20.2 APR Orally Dissolving Film Drug Description and Business Overview
      • 6.20.3 APR Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
      • 6.20.4 APR Orally Dissolving Film Drug Product Portfolio
      • 6.20.5 APR Recent Developments/Updates

    7 Orally Dissolving Film Drug Manufacturing Cost Analysis

    • 7.1 Orally Dissolving Film Drug Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Orally Dissolving Film Drug
    • 7.4 Orally Dissolving Film Drug Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Orally Dissolving Film Drug Distributors List
    • 8.3 Orally Dissolving Film Drug Customers

    9 Orally Dissolving Film Drug Market Dynamics

    • 9.1 Orally Dissolving Film Drug Industry Trends
    • 9.2 Orally Dissolving Film Drug Market Drivers
    • 9.3 Orally Dissolving Film Drug Market Challenges
    • 9.4 Orally Dissolving Film Drug Market Restraints

    10 Global Market Forecast

    • 10.1 Orally Dissolving Film Drug Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Orally Dissolving Film Drug by Type (2023-2028)
      • 10.1.2 Global Forecasted Revenue of Orally Dissolving Film Drug by Type (2023-2028)
    • 10.2 Orally Dissolving Film Drug Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Orally Dissolving Film Drug by Application (2023-2028)
      • 10.2.2 Global Forecasted Revenue of Orally Dissolving Film Drug by Application (2023-2028)
    • 10.3 Orally Dissolving Film Drug Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Orally Dissolving Film Drug by Region (2023-2028)
      • 10.3.2 Global Forecasted Revenue of Orally Dissolving Film Drug by Region (2023-2028)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      Summary:
      Get latest Market Research Reports on Orally Dissolving Film Drug. Industry analysis & Market Report on Orally Dissolving Film Drug is a syndicated market report, published as Global Orally Dissolving Film Drug Market Research Report 2022. It is complete Research Study and Industry Analysis of Orally Dissolving Film Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,395.40
      4,790.80
      2,781.10
      5,562.20
      393,269.00
      786,538.00
      228,694.00
      457,388.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report